Sanofi EPS - Earnings per Share 2010-2025 | SNY

Sanofi earnings per share (EPS) for the twelve months ending March 31, 2025 was $2.70, a 37.68% increase year-over-year.

  • Sanofi EPS for the quarter ending March 31, 2025 was $0.80, a 62.15% increase year-over-year.
  • Sanofi 2024 annual EPS was $2.4, a 3.01% increase from 2023.
  • Sanofi 2023 annual EPS was $2.33, a 33.68% decline from 2022.
  • Sanofi 2022 annual EPS was $3.51, a 19.84% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Sanofi EPS - Earnings per Share 2010-2025 | SNY

  • Sanofi EPS for the quarter ending March 31, 2025 was $0.80, a 62.15% increase year-over-year.
  • Sanofi 2024 annual EPS was $2.4, a 3.01% increase from 2023.
  • Sanofi 2023 annual EPS was $2.33, a 33.68% decline from 2022.
  • Sanofi 2022 annual EPS was $3.51, a 19.84% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B